Send mail to Author

A randomized phase IIa trial with temsirolimus versus sunitinib in advanced non-clear cell renal cell carcinoma: an intergroup study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    _____     _  __   _    _     ____       ___    
 /_   _//  |  ___||  | |/ // | || | ||  |  _ \\    / _ \\  
   | ||    | ||__    | ' //  | || | ||  | |_| ||  | / \ || 
  _| ||    | ||__    | . \\  | \\_/ ||  | .  //   | \_/ || 
 /__//     |_____||  |_|\_\\  \____//   |_|\_\\    \___//  
 `--`      `-----`   `-` --`   `---`    `-` --`    `---`   
                                                           
 


Back to frontdoor view